Newsmax (News)
NOTE: AllSides does not rate Newsmax TV; this rating is for Newsmax's online, written content only. AllSides rates Newsmax opinion content separately.
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S. Federal Trade Commission said Tuesday. From 2017 to 2022, the companies — UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts — marked up prices at their affiliated pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue in excess of the acquisition costs of the drugs, the FTC said in its second report on the...